相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
Timothy C. Johnstone et al.
CHEMICAL REVIEWS (2016)
Unique Use of Alkylation for Chemo-Redox Activity by a PtIV Prodrug
Rakesh K. Pathak et al.
CHEMISTRY-A EUROPEAN JOURNAL (2016)
Platinum(IV) anticancer prodrugs - hypotheses and facts
Dan Gibson
DALTON TRANSACTIONS (2016)
Combined Chemo-Anti-Inflammatory Prodrugs and Nanoparticles
Rakesh K. Pathak et al.
SYNLETT (2016)
Pt(IV) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
Raji Raveendran et al.
CHEMICAL SCIENCE (2016)
Functionalization of Platinum Complexes for Biomedical Applications
Xiaoyong Wang et al.
ACCOUNTS OF CHEMICAL RESEARCH (2015)
Oral delivery of a platinum anticancer drug using lipid assisted polymeric nanoparticles
Qinqin Cheng et al.
CHEMICAL COMMUNICATIONS (2015)
Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides
Anna Massaguer et al.
DALTON TRANSACTIONS (2015)
A Nanoparticle Cocktail: Temporal Release of Predefined Drug Combinations
Rakesh K. Pathak et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Evaluation of nanoparticle delivered cisplatin in beagles
Brittany Feldhaeusser et al.
NANOSCALE (2015)
Covalent and non-covalent curcumin loading in acid-responsive polymeric micellar nanocarriers
Min Gao et al.
NANOTECHNOLOGY (2015)
Targeted delivery of photoactive diazido Pt-IV complexes conjugated with fluorescent carbon dots
Xiao-Dong Yang et al.
NEW JOURNAL OF CHEMISTRY (2015)
Phase 1 Trial and Pharmacokinetic Study of the Oral Platinum Analog Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors
Srivandana Akshintala et al.
PEDIATRIC BLOOD & CANCER (2015)
Conjugation of Cisplatin Analogues and Cyclooxygenase Inhibitors to Overcome Cisplatin Resistance
Wilma Neumann et al.
CHEMMEDCHEM (2015)
The Prodrug Platin-A: Simultaneous Release of Cisplatin and Aspirin
Rakesh K. Pathak et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI
Ziyong Cheng et al.
BIOMATERIALS (2014)
Conjugation of vitamin E analog α-TOS to Pt(IV) complexes for dual-targeting anticancer therapy
Kogularamanan Suntharalingam et al.
CHEMICAL COMMUNICATIONS (2014)
The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells
Qinqin Cheng et al.
CHEMICAL COMMUNICATIONS (2014)
Synthetic Methods for the Preparation of Platinum Anticancer Complexes
Justin J. Wilson et al.
CHEMICAL REVIEWS (2014)
Copper-Free Click-Chemistry Platform to Functionalize Cisplatin Prodrugs
Rakesh K. Pathak et al.
CHEMISTRY-A EUROPEAN JOURNAL (2014)
Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
Yao-Rong Zheng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin
Longyan Liao et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Detouring of cisplatin to access mitochondrial genome for overcoming resistance
Sean Marrache et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Ratiometric delivery of cisplatin and doxorubicin using tumour-targeting carbon-nanotubes entrapping platinum(IV) prodrugs
Chee Fei Chin et al.
CHEMICAL SCIENCE (2014)
Ex Vivo Programming of Dendritic Cells by Mitochondria-Targeted Nanoparticles to Produce Interferon-Gamma for Cancer Immunotherapy
Sean Marrache et al.
ACS NANO (2013)
Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer
Krushna C. Patra et al.
CANCER CELL (2013)
Maleimide-functionalised platinum(IV) complexes as a synthetic platform for targeted drug delivery
Verena Pichler et al.
CHEMICAL COMMUNICATIONS (2013)
Targeting and delivery of platinum-based anticancer drugs
Xiaoyong Wang et al.
CHEMICAL SOCIETY REVIEWS (2013)
Targeting Mitochondrial DNA with a Platinum-Based Anticancer Agent
Simon P. Wisnovsky et al.
CHEMISTRY & BIOLOGY (2013)
Facile Preparation of Mono-, Di- and Mixed-Carboxylato Platinum(IV) Complexes for Versatile Anticancer Prodrug Design
Jenny Z. Zhang et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Multifunctionalization of Polymers by Strain-Promoted Cycloadditions
Petr A. Ledin et al.
MACROMOLECULES (2013)
Epistatic role of base excision repair and mismatch repair pathways in mediating cisplatin cytotoxicity
Anbarasi Kothandapani et al.
NUCLEIC ACIDS RESEARCH (2013)
Drug Delivery: Platinum (IV) Pro-Drug Conjugated NaYF4:Yb3+/Er3+Nanoparticles for Targeted Drug Delivery and Up-Conversion Cell Imaging (Adv. Healthcare Mater. 4/2013)
Yunlu Dai et al.
Advanced Healthcare Materials (2013)
Targeting carbon nanotubes against cancer
Chiara Fabbro et al.
CHEMICAL COMMUNICATIONS (2012)
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Nazila Kamaly et al.
CHEMICAL SOCIETY REVIEWS (2012)
Solid-phase synthesis of oxaliplatin-TAT peptide bioconjugates
Sergey Abramkin et al.
DALTON TRANSACTIONS (2012)
Harnessing chemoselective imine ligation for tethering bioactive molecules to platinum(IV) prodrugs
Daniel Yuan Qiang Wong et al.
DALTON TRANSACTIONS (2012)
Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells
Nora Graf et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Conjugate of Pt(IV)-Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy
Jun Yang et al.
MOLECULAR PHARMACEUTICS (2012)
Nanoparticles: the future for platinum drugs or a research red herring?
Nial J. Wheate
NANOMEDICINE (2012)
Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics
Sean Marrache et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Applications of Cell-Penetrating Peptides for Tumor Targeting and Future Cancer Therapies
Jakob Regberg et al.
PHARMACEUTICALS (2012)
From Mechanism to Mouse: A Tale of Two Bioorthogonal Reactions
Ellen M. Sletten et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Sarbari Acharya et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
Jun Fang et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Prostaglandins and Inflammation
Emanuela Ricciotti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Adamantane-platinum conjugate hosted in β-cyclodextrin: Enhancing transport and cytotoxicity by noncovalent modification
Deepali Prashar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Novel Role of Base Excision Repair in Mediating Cisplatin Cytotoxicity
Anbarasi Kothandapani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Vitamin B-12 as a carrier for targeted platinum delivery: in vitro cytotoxicity and mechanistic studies
Pilar Ruiz-Sanchez et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2011)
Targeted drug delivery to tumors: Myths, reality and possibility
You Han Bae et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Prodrugs-from Serendipity to Rational Design
Kristiina M. Huttunen et al.
PHARMACOLOGICAL REVIEWS (2011)
Otto Warburg's contributions to current concepts of cancer metabolism
Willem H. Koppenol et al.
NATURE REVIEWS CANCER (2011)
A Potent Trans-Diimine Platinum Anticancer Complex Photoactivated by Visible Light
Nicola J. Farrer et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Platinum(II) compounds bearing bone-targeting group: synthesis, crystal structure and antitumor activity
Zuqin Xue et al.
CHEMICAL COMMUNICATIONS (2010)
Gold nanorods for platinum based prodrug delivery
Yuanzeng Min et al.
CHEMICAL COMMUNICATIONS (2010)
The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin
Anamaria Brozovic et al.
CRITICAL REVIEWS IN TOXICOLOGY (2010)
Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles - opportunities & challenges
Jessica M. Rosenholm et al.
NANOSCALE (2010)
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
Nagesh Kolishetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
Ellen M. Sletten et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Functionalized Cyclic RGD Peptidomimetics: Conjugable ligands for αvβ3 Receptor Imaging
Daniela Arosio et al.
BIOCONJUGATE CHEMISTRY (2009)
Mechanistic Insights into Cyclooxygenase Irreversible Inactivation by Aspirin
Paolo Tosco et al.
CHEMMEDCHEM (2009)
Satraplatin, an Oral Platinum, Administered on a Five-day Every-Five-Week Schedule: a Pharmacokinetic and Food Effect Study
Alejandro D. Ricart et al.
CLINICAL CANCER RESEARCH (2009)
Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and Carboplatin
Brian G. Blair et al.
CLINICAL CANCER RESEARCH (2009)
Potential applications of metal-organic frameworks
Ryan J. Kuppler et al.
COORDINATION CHEMISTRY REVIEWS (2009)
Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin
Ruimin Xing et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
A bifunctional platinum(II) antitumor agent that forms DNA adducts with affinity for the estrogen receptor
Eunsuk Kim et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Is Glutathione the Major Cellular Target of Cisplatin? A Study of the Interactions of Cisplatin with Cancer Cell Extracts
Yonit Kasherman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Postsynthetic Modifications of Iron-Carboxylate Nanoscale Metal-Organic Frameworks for Imaging and Drug Delivery
Kathryn M. L. Taylor-Pashow et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
Shanta Dhar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Toxicity of single-walled carbon nanohorns
Jin Miyawaki et al.
ACS NANO (2008)
Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature
Sumitra Mukhopadhyay et al.
BIOCONJUGATE CHEMISTRY (2008)
Prodrug strategies in anticancer chemotherapy
Felix Kratz et al.
CHEMMEDCHEM (2008)
Platinum resistance: The role of DNA repair pathways
Lainie P. Martin et al.
CLINICAL CANCER RESEARCH (2008)
Recent trends in targeted anticancer prodrug and conjugate design
Yashveer Singh et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Nanotechnology for drug delivery: the perfect partnership
Omid C. Farokhzad
EXPERT OPINION ON DRUG DELIVERY (2008)
Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation
Young-Il Jeong et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Nanoscale coordination polymers for platinum-based anticancer drug delivery
William J. Rieter et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device
Shanta Dhar et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Prodrugs: design and clinical applications
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Basis for design and development of Platinum(IV) anticancer complexes
Matthew D. Hall et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Platinum complexes can inhibit matrix metalloproteinase activity: Platinum-diethyl[(methylsulfinyl)methyl]phosphonate complexes as inhibitors of matrix metalloproteinases 2, 3, 9, and 12
Rossella Sasanelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Synthesis and characterization of a platinum(II) complex tethered to a ligand of the peripheral benzodiazepine receptor
Nicola Margiotta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer
Kevin J. Cullen et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2007)
Some uses of transition metal complexes as anti-cancer and anti-HIV agents
Raymond Wai-Yin Sun et al.
DALTON TRANSACTIONS (2007)
A glucose derivative as natural alternative to the cyclohexane-1,2-diamine ligand in the anticancer drug oxaliplatin?
Isabella Berger et al.
CHEMMEDCHEM (2007)
Heparanase, hyaluronan, and CD44 in cancers:: A breast carcinoma perspective
Martin Gotte et al.
CANCER RESEARCH (2006)
Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: Possible role in apoptosis
Zejia Yang et al.
CLINICAL CANCER RESEARCH (2006)
Bisphosphonate actions: Physical chemistry revisited
Socrates E. Papapoulos
BONE (2006)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance
WH Ang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
S Ishida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues
MJ Thun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Studies of the binding of a series of platinum(IV) complexes to plasma proteins
RC Dolman et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2002)
分享论文
